论文部分内容阅读
多种菌苗制剂 Broncasma Berna 是瑞士血清菌苗研究所发明(卡他球菌属6000万;肺炎双球菌5000万;链球菌4000万;葡萄球菌5亿;绿脓杆菌2亿5000万;四联球菌属2000万;肺炎荚膜杆菌4000万;流感嗜血杆菌4000万)。在日本最近有很多关于对支气管喘息治疗有效的报导。例如宫本等用双盲检查法,报导本药对支气管喘息有效,尤其是对感染型的效果较之过敏型效果好。
Broncasma Berna was invented by the Swiss Serum Vaccine Institute (Vaccinium spp. 60 million; Streptococcus pneumoniae 50 million; Streptococcus 40 million; Staphylococcus aureus 500 million; Pseudomonas aeruginosa 250 million; 20 million; Pneumococcus 40 million; Haemophilus influenzae 40 million). There have been many recent reports in Japan about effective treatment of bronchial asthma. For example, Miyamoto and other double-blind check, reported that the drug effective bronchial asthma, especially for the effect of the type of infection than the allergy-type effect.